Merck 2026 Sales Forecast Faces Challenges Amid HPV and New
The Merck 2026 sales forecast has been revised downward due to ongoing issues with Gardasil, impacting the company's growth outlook despite efforts in newer
Merck bond issuance: Up to Eight Series of Bonds to Fund
Merck bond issuance is a strategic move by pharmaceutical giant Merck & Co to raise funds for its acquisition of Cidara Therapeutics and support its growth